Yazıcı, OnurBozkus, FulsenDemirci, Nilgun YilmazGülhan, Pınar YıldızCoskun, Funda2021-12-012021-12-0120202148-36202148-5402https://doi.org/10.4103/ejop.ejop_49_20https://app.trdizin.gov.tr/makale/TXpnNE9EazVPUT09https://hdl.handle.net/20.500.12684/9707Caused by severe acute respiratory syndrome?coronavirus?2 (SARS?CoV?2), coronavirus disease2019 (COVID?19) is a potentially fatal disease as a global public health issue. Several mechanismsmay be involved in mortality. One of these is coagulopathy and disseminated intravascular coagulationcaused by SARS?CoV?2. When patients have coagulation disorders, treatment becomes morechallenging and mortality rate increases accordingly. The aim of this article is to review the potentialmechanisms of coagulopathy in COVID?19 in light of literature data.en10.4103/ejop.ejop_49_20info:eu-repo/semantics/openAccess[No Keywords]Article2216769WOS:000578603800014N/A